{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:40:34Z","timestamp":1791765634545,"version":"4.3.4"},"reference-count":132,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_175639"],"award-info":[{"award-number":["310030_175639"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Folates are water-soluble B9 vitamins that serve as one-carbon donors in the de novo synthesis of thymidylate and purines, and in the conversion of homocysteine to methionine. Due to their key roles in nucleic acid synthesis and in DNA methylation, inhibiting the folate pathway is still one of the most efficient approaches for the treatment of several tumors. Methotrexate and pemetrexed are the most prescribed antifolates and are mainly used in the treatment of acute myeloid leukemia, osteosarcoma, and lung cancers. Normal levels of folates in the blood are maintained not only by proper dietary intake and intestinal absorption, but also by an efficient renal reabsorption that seems to be primarily mediated by the glycosylphosphatidylinositol- (GPI) anchored protein folate receptor \u03b1 (FR\u03b1), which is highly expressed at the brush-border membrane of proximal tubule cells. Folate deficiency due to malnutrition, impaired intestinal absorption or increased urinary elimination is associated with severe hematological and neurological deficits. This review describes the role of the kidneys in folate homeostasis, the molecular basis of folate handling by the kidneys, and the use of high dose folic acid as a model of acute kidney injury. Finally, we provide an overview on the development of folate-based compounds and their possible therapeutic potential and toxicological ramifications.<\/jats:p>","DOI":"10.3390\/nu11102353","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T03:41:27Z","timestamp":1570074087000},"page":"2353","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Renal Reabsorption of Folates: Pharmacological and Toxicological Snapshots"],"prefix":"10.3390","volume":"11","author":[{"given":"Sophia L","family":"Samodelov","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8006 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Gai","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8006 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd A","family":"Kullak-Ublick","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8006 Zurich, Switzerland"},{"name":"Mechanistic Safety, CMO &amp; Patient Safety, Global Drug Development, Novartis Pharma, 4056 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Visentin","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, 8006 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,2]]},"reference":[{"key":"ref_1","first-page":"93","article-title":"Folic acid supplementation on homocysteine levels in children taking antiepileptic drugs: A randomized controlled trial","volume":"5","author":"Jeeja","year":"2014","journal-title":"J. Pharm. Pharm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.ATV.18.3.356","article-title":"Vitamin supplementation reduces blood homocysteine levels: A controlled trial in patients with venous thrombosis and healthy volunteers","volume":"18","author":"Brouwer","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_3","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Stephens, K., and Amemiya, A. (1993). Hereditary Folate Malabsorption. GeneReviews, University of Washington."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.hoc.2012.02.002","article-title":"The antifolates","volume":"26","author":"Visentin","year":"2012","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1079\/BJN2002733","article-title":"The effect of different cooking methods on folate retention in various foods that are amongst the major contributors to folate intake in the UK diet","volume":"88","author":"McKillop","year":"2002","journal-title":"Br. J. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11130-012-0312-2","article-title":"Effect of freezing technology and storage conditions on folate content in selected vegetables","volume":"67","author":"Czarnowska","year":"2012","journal-title":"Plant Foods Hum. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1017\/S0007114515001142","article-title":"Folate status and concentrations of serum folate forms in the US population: National Health and Nutrition Examination Survey 2011-2","volume":"113","author":"Pfeiffer","year":"2015","journal-title":"Br. J. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/ajcn\/88.3.763","article-title":"Circulating folic acid in plasma: Relation to folic acid fortification","volume":"88","author":"Kalmbach","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-physiol-020911-153251","article-title":"The intestinal absorption of folates","volume":"76","author":"Visentin","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cell.2006.09.041","article-title":"Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption","volume":"127","author":"Qiu","year":"2006","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1182\/blood-2010-06-291237","article-title":"Functional roles of aspartate residues of the proton-coupled folate transporter (PCFT-SLC46A1); a D156Y mutation causing hereditary folate malabsorption","volume":"116","author":"Shin","year":"2010","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1182\/blood-2010-04-279653","article-title":"A mouse model of hereditary folate malabsorption: Deletion of the PCFT gene leads to systemic folate deficiency","volume":"117","author":"Salojin","year":"2011","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/mol.109.055392","article-title":"Vitamin D3 and its nuclear receptor increase the expression and activity of the human proton-coupled folate transporter","volume":"76","author":"Eloranta","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00228-016-2050-0","article-title":"No major effects of vitamin D3 (1,25 dihydroxyvitamin D3) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers","volume":"72","author":"Gubler","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jcp.22525","article-title":"Reduced levels of folate transporters (PCFT and RFC) in membrane lipid rafts result in colonic folate malabsorption in chronic alcoholism","volume":"226","author":"Wani","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"F22","DOI":"10.1152\/ajprenal.00385.2005","article-title":"The kidney in vitamin B12 and folate homeostasis: Characterization of receptors for tubular uptake of vitamins and carrier proteins","volume":"291","author":"Birn","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/00365517609055264","article-title":"Folic acid binding by human plasma albumin","volume":"36","author":"Soliman","year":"1976","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-nutr-072610-145133","article-title":"Mechanisms of membrane transport of folates into cells and across epithelia","volume":"31","author":"Zhao","year":"2011","journal-title":"Annu. Rev. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/bdra.20453","article-title":"Embryonic development in the reduced folate carrier knockout mouse is modulated by maternal folate supplementation","volume":"82","author":"Heller","year":"2008","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1681\/ASN.2004080711","article-title":"Renal tubular reabsorption of folate mediated by folate binding protein 1","volume":"16","author":"Birn","year":"2005","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v15.i6.20","article-title":"Folate-mediated targeting of therapeutic and imaging agents to cancers","volume":"15","author":"Reddy","year":"1998","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"ref_22","first-page":"F750","article-title":"Renal folate absorption and the kidney folate binding protein. I. Urinary clearance studies","volume":"252","author":"Selhub","year":"1987","journal-title":"Am. J. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1093\/jn\/122.12.2415","article-title":"5-Methyltetrahydrofolate is reabsorbed and metabolized in isolated perfused rat kidney","volume":"122","author":"Muldoon","year":"1992","journal-title":"J. Nutr."},{"key":"ref_24","first-page":"F70","article-title":"Internalization and apical-to-basolateral transport of folate in rat kidney proximal tubule","volume":"272","author":"Birn","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1016\/S0021-9258(20)82184-X","article-title":"The folate-binding protein of rat kidney. Purification, properties, and cellular distribution","volume":"259","author":"Selhub","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.addr.2004.01.002","article-title":"A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro","volume":"56","author":"Kamen","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.bbapap.2015.06.009","article-title":"The complex interplay between ligand binding and conformational structure of the folate binding protein (folate receptor): Biological perspectives","volume":"1854","author":"Holm","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1083\/jcb.134.5.1169","article-title":"Clustered folate receptors deliver 5-methyltetrahydrofolate to cytoplasm of MA104 cells","volume":"134","author":"Smart","year":"1996","journal-title":"J. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1083\/jcb.118.1.63","article-title":"Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate","volume":"118","author":"Chang","year":"1992","journal-title":"J. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1091\/mbc.6.7.929","article-title":"Insolubility and redistribution of GPI-anchored proteins at the cell surface after detergent treatment","volume":"6","author":"Mayor","year":"1995","journal-title":"Mol. Biol. Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1083\/jcb.132.1.35","article-title":"Endocytosis of GPI-linked membrane folate receptor-alpha","volume":"132","author":"Rijnboutt","year":"1996","journal-title":"J. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.addr.2004.01.010","article-title":"Folate receptor endocytosis and trafficking","volume":"56","author":"Sabharanjak","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"C517","DOI":"10.1152\/ajpcell.00006.2004","article-title":"Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy","volume":"287","author":"Sandoval","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1111\/j.1742-4658.2005.04857.x","article-title":"Megalin binds and mediates cellular internalization of folate binding protein","volume":"272","author":"Birn","year":"2005","journal-title":"FEBS J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrm778","article-title":"Megalin and cubilin: Multifunctional endocytic receptors","volume":"3","author":"Christensen","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2141.1975.tb01796.x","article-title":"Folate binding proteins","volume":"29","author":"Waxman","year":"1975","journal-title":"Br. J. Haematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/jn\/127.6.1137","article-title":"Folate transport proteins mediate the bidirectional transport of 5-methyltetrahydrofolate in cultured human proximal tubule cells","volume":"127","author":"Morshed","year":"1997","journal-title":"J. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0005-2736(01)00340-6","article-title":"Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis","volume":"1513","author":"Wang","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_39","first-page":"3396","article-title":"Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues","volume":"52","author":"Weitman","year":"1992","journal-title":"Cancer Res."},{"key":"ref_40","first-page":"6708","article-title":"Cellular localization of the folate receptor: Potential role in drug toxicity and folate homeostasis","volume":"52","author":"Weitman","year":"1992","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0079-6603(01)67027-2","article-title":"Molecular and cellular biology of the human reduced folate carrier","volume":"67","author":"Matherly","year":"2001","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0083-6729(03)01012-4","article-title":"Membrane transport of folates","volume":"66","author":"Matherly","year":"2003","journal-title":"Vitam. Horm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/S1462399409000969","article-title":"Membrane transporters and folate homeostasis: Intestinal absorption and transport into systemic compartments and tissues","volume":"11","author":"Zhao","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/mol.108.045443","article-title":"The proton-coupled folate transporter: Impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier","volume":"74","author":"Zhao","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1167\/iovs.09-4833","article-title":"Molecular and biochemical characterization of folate transport proteins in retinal Muller cells","volume":"51","author":"Bozard","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12576-012-0223-x","article-title":"Adaptive transport of folic acid across renal epithelia in folate-deficient rats","volume":"62","author":"Wani","year":"2012","journal-title":"J. Physiol. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0083-6729(08)00406-8","article-title":"Renal conservation of folates role of folate transport proteins","volume":"79","author":"Damaraju","year":"2008","journal-title":"Vitam. Horm."},{"key":"ref_48","first-page":"3144","article-title":"Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system","volume":"62","author":"Chen","year":"2002","journal-title":"Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15181","DOI":"10.1074\/jbc.274.21.15181","article-title":"Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3)","volume":"274","author":"Hirohashi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_50","first-page":"2532","article-title":"Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2","volume":"59","author":"Hooijberg","year":"1999","journal-title":"Cancer Res."},{"key":"ref_51","first-page":"G789","article-title":"Reduced folate derivatives are endogenous substrates for cMOAT in rats","volume":"275","author":"Kusuhara","year":"1998","journal-title":"Am. J. Physiol."},{"key":"ref_52","first-page":"4779","article-title":"Transport of amphipathic anions by human multidrug resistance protein 3","volume":"60","author":"Zeng","year":"2000","journal-title":"Cancer Res."},{"key":"ref_53","first-page":"7225","article-title":"Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: Effect of polyglutamylation on MTX transport","volume":"61","author":"Zeng","year":"2001","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.V133595","article-title":"The MRP4\/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: Putative efflux pump for urinary cAMP and cGMP","volume":"13","author":"Smeets","year":"2002","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1681\/ASN.V881213","article-title":"Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules","volume":"8","author":"Schaub","year":"1997","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1158\/0008-5472.CAN-06-4720","article-title":"Substrate overlap between Mrp4 and Abcg2\/Bcrp affects purine analogue drug cytotoxicity and tissue distribution","volume":"67","author":"Takenaka","year":"2007","journal-title":"Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/labinvest.3780411","article-title":"Tissue distribution and induction of human multidrug resistant protein 3","volume":"82","author":"Scheffer","year":"2002","journal-title":"Lab. Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2133\/dmpk.18.91","article-title":"Functional characteristics and pharmacokinetic significance of kidney-specific organic anion transporters, OAT-K1 and OAT-K2, in the urinary excretion of anionic drugs","volume":"18","author":"Masuda","year":"2003","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0014-5793(98)01328-3","article-title":"Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney","volume":"438","author":"Uwai","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/bbrc.2001.4774","article-title":"Isolation of a family of organic anion transporters from human liver and kidney","volume":"283","author":"Sun","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01306-7","article-title":"Interaction of human organic anion transporters with various cephalosporin antibiotics","volume":"438","author":"Takeda","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"ref_62","first-page":"F295","article-title":"Cloning of the human kidney PAH transporter: Narrow substrate specificity and regulation by protein kinase C","volume":"276","author":"Lu","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.kint.2016.09.019","article-title":"Folic acid supplementation and chronic kidney disease progression","volume":"90","author":"Wyatt","year":"2016","journal-title":"Kidney Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e6591","DOI":"10.5867\/medwave.2016.6591","article-title":"Is folic acid supplementation useful for chronic kidney disease?","volume":"16","author":"Madrid","year":"2016","journal-title":"Medwave"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O\u2019Callaghan, C.A., Lasserson, D.S., and Hobbs, F.D. (2016). Global Prevalence of Chronic Kidney Disease-A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158765"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.1997.298","article-title":"Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes","volume":"52","author":"Bostom","year":"1997","journal-title":"Kidney Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1515\/CCLM.2007.335","article-title":"Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients","volume":"45","author":"Righetti","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14779072.2018.1497974","article-title":"The current status of homocysteine as a risk factor for cardiovascular disease: A mini review","volume":"16","author":"Chrysant","year":"2018","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/j.ajkd.2009.12.035","article-title":"Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis","volume":"55","author":"Koyama","year":"2010","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage, J.M., Bowman, L., Clarke, R.J., Wallendszus, K., Bulbulia, R., Rahimi, K., Haynes, R., Parish, S., and Sleight, P. (2010). Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: A randomized trial. JAMA J. Am. Med Assoc., 303, 2486\u20132494.","DOI":"10.1001\/jama.2010.840"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MAJ.0b013e3181aaefd6","article-title":"Folic acid supplementation and cardiovascular disease: The state of the art","volume":"338","author":"Bazzano","year":"2009","journal-title":"Am. J. Med Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/CIRCULATIONAHA.109.904672","article-title":"B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: Results of a randomized controlled trial","volume":"121","author":"Heinz","year":"2010","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: A randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: Primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"123","author":"Bostom","year":"2011","journal-title":"Circulation"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2215\/CJN.05310610","article-title":"Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: A meta-analysis","volume":"6","author":"Qin","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/212472a0","article-title":"Stimulation of renal growth in the rat by folic acid","volume":"212","author":"Taylor","year":"1966","journal-title":"Nature"},{"key":"ref_77","first-page":"1","article-title":"Studies of the changes in growth and DNA synthesis in the rat kidney during experimentally induced renal hypertrophy","volume":"50","author":"Threlfall","year":"1967","journal-title":"Am. J. Pathol."},{"key":"ref_78","first-page":"1477","article-title":"The effect of folic acid on growth and deoxyribonucleic acid synthesis in the rat kidney","volume":"15","author":"Threlfall","year":"1966","journal-title":"Lab. Investig."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/path.5282","article-title":"PGC-1alpha deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI","volume":"249","author":"Carrasco","year":"2019","journal-title":"J. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.kint.2018.11.043","article-title":"Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration","volume":"95","author":"Fu","year":"2019","journal-title":"Kidney Int."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI121987","article-title":"PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease","volume":"129","author":"Li","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.freeradbiomed.2018.11.005","article-title":"Protective effects of N-acetyl-cysteine in mitochondria bioenergetics, oxidative stress, dynamics and S-glutathionylation alterations in acute kidney damage induced by folic acid","volume":"130","author":"Tapia","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00997785","article-title":"Regeneration of renal tubular cells after lesion by temporary ischaemia, folic acid, and 2,4,5-triamino 6-styrylpyrimidine","volume":"266","author":"Brade","year":"1970","journal-title":"Naunyn Schmiedebergs Arch. Pharmakol."},{"key":"ref_84","first-page":"191","article-title":"Response of the rat kidney to folic acid administration. II. Morphologic studies","volume":"26","author":"Byrnes","year":"1972","journal-title":"Lab. Investig."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2362.1973.tb00346.x","article-title":"Acute renal failure after folate: NaK ATPase in isolated rat renal tubule. Ultramicrochemical and clinical studies","volume":"3","author":"Schmidt","year":"1973","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"F1252","DOI":"10.1152\/ajprenal.00128.2018","article-title":"Multiparametric MRI detects longitudinal evolution of folic acid-induced nephropathy in mice","volume":"315","author":"Jiang","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1681\/ASN.2015080898","article-title":"Mitogen-Activated Protein Kinase 14 Promotes AKI","volume":"28","author":"Ortiz","year":"2017","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Husi, H., Sanchez-Nino, M.D., Delles, C., Mullen, W., Vlahou, A., Ortiz, A., and Mischak, H. (2013). A combinatorial approach of Proteomics and Systems Biology in unravelling the mechanisms of acute kidney injury (AKI): Involvement of NMDA receptor GRIN1 in murine AKI. BMC Syst. Biol., 7.","DOI":"10.1186\/1752-0509-7-110"},{"key":"ref_89","first-page":"208","article-title":"The occurrence of lipid droplets in the proximal and distal tubules of the rat kidney after folic acid treatment","volume":"17","author":"Petorak","year":"1979","journal-title":"Exp. Pathol. (Jena)"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.2015121376","article-title":"Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI","volume":"28","author":"Poveda","year":"2017","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: Opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1073\/pnas.1716578115","article-title":"TWEAK and RIPK1 mediate a second wave of cell death during AKI","volume":"115","author":"Carrasco","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1681\/ASN.2016091001","article-title":"Inhibition of Reticulon-1A-Mediated Endoplasmic Reticulum Stress in Early AKI Attenuates Renal Fibrosis Development","volume":"28","author":"Fan","year":"2017","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_95","first-page":"23","article-title":"Effects of folic acid on glucose-6-phosphate dehydrogenase and renin activities of the rat kidney","volume":"20","author":"Yamamoto","year":"1974","journal-title":"Osaka City Med. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"36698","DOI":"10.1038\/srep36698","article-title":"Rescue therapy with Tanshinone IIA hinders transition of acute kidney injury to chronic kidney disease via targeting GSK3beta","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.toxlet.2013.11.014","article-title":"Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis","volume":"224","author":"Stallons","year":"2014","journal-title":"Toxicol. Lett."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1681\/ASN.2015020225","article-title":"RNA Sequencing Identifies Novel Translational Biomarkers of Kidney Fibrosis","volume":"27","author":"Craciun","year":"2016","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0002-9440(10)63586-9","article-title":"Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha","volume":"163","author":"Yuan","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","article-title":"Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay","volume":"338","author":"Parker","year":"2005","journal-title":"Anal. Biochem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/bj2800267","article-title":"High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein","volume":"280","author":"Holm","year":"1991","journal-title":"Biochem. J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"9684","DOI":"10.1016\/S0021-9258(19)68817-4","article-title":"Isolation and characterization of a folate receptor from human placenta","volume":"256","author":"Antony","year":"1981","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/ncomms3123","article-title":"Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma","volume":"4","author":"Grapp","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1158\/0008-5472.CAN-07-0033","article-title":"Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate","volume":"67","author":"Reddy","year":"2007","journal-title":"Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1200\/JCO.2011.41.4946","article-title":"Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumors","volume":"30","author":"Lorusso","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1200\/JCO.2013.49.7685","article-title":"PRECEDENT: A randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer","volume":"31","author":"Naumann","year":"2013","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1021\/bc060145g","article-title":"Synthesis and biological evaluation of EC140: A novel folate-targeted vinca alkaloid conjugate","volume":"17","author":"Leamon","year":"2006","journal-title":"Bioconjug Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.1158\/0008-5472.CAN-06-3894","article-title":"Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate","volume":"67","author":"Reddy","year":"2007","journal-title":"Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"9839","DOI":"10.1158\/0008-5472.CAN-08-2341","article-title":"Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue","volume":"68","author":"Leamon","year":"2008","journal-title":"Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.addr.2004.01.008","article-title":"Folate-targeted chemotherapy","volume":"56","author":"Leamon","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_111","first-page":"857","article-title":"Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors","volume":"45","author":"Reddy","year":"2004","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00259-006-0111-9","article-title":"Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting","volume":"33","author":"Muller","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00280-015-2733-8","article-title":"Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis","volume":"75","author":"Zhao","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_114","first-page":"2057","article-title":"Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo","volume":"47","author":"Muller","year":"2006","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s00259-008-1058-9","article-title":"Evaluation of a novel radiofolate in tumour-bearing mice: Promising prospects for folate-based radionuclide therapy","volume":"36","author":"Muller","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.nucmedbio.2007.06.001","article-title":"Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys","volume":"34","author":"Muller","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1021\/mp900296k","article-title":"Effects of the antifolates pemetrexed and CB3717 on the tissue distribution of (99m)Tc-EC20 in xenografted and syngeneic tumor-bearing mice","volume":"7","author":"Muller","year":"2010","journal-title":"Mol. Pharm."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/mp200511t","article-title":"Radioiodinated folic acid conjugates: Evaluation of a valuable concept to improve tumor-to-background contrast","volume":"9","author":"Reber","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/cphy.c160018","article-title":"Polycystic Kidney Disease","volume":"7","author":"Ghata","year":"2017","journal-title":"Compr. Physiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","volume":"371","author":"Torres","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_123","first-page":"598","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJMe1006925","article-title":"mTOR inhibitors in polycystic kidney disease","volume":"363","author":"Watnick","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1681\/ASN.2012040367","article-title":"Folate-conjugated rapamycin slows progression of polycystic kidney disease","volume":"23","author":"Shillingford","year":"2012","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"F395","DOI":"10.1152\/ajprenal.00057.2018","article-title":"Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease","volume":"315","author":"Kipp","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.11.019","article-title":"Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys","volume":"293","author":"Shi","year":"2019","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s13346-018-0589-2","article-title":"The folate receptor beta as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis","volume":"9","author":"Chandrupatla","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1021\/acs.molpharmaceut.9b00624","article-title":"Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys","volume":"16","author":"Chu","year":"2019","journal-title":"Mol. Pharm."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/11\/10\/2353\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:27:12Z","timestamp":1760189232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/11\/10\/2353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,2]]},"references-count":132,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["nu11102353"],"URL":"https:\/\/doi.org\/10.3390\/nu11102353","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,2]]}}}